GoalVest Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $162K | Buy |
399
+74
| +23% | +$30K | 0.04% | 142 |
|
2025
Q1 | $162K | Buy |
325
+149
| +85% | +$74.1K | 0.04% | 129 |
|
2024
Q4 | $91.6K | Buy |
176
+6
| +4% | +$3.12K | 0.03% | 150 |
|
2024
Q3 | $105K | Hold |
170
| – | – | 0.03% | 139 |
|
2024
Q2 | $94K | Sell |
170
-84
| -33% | -$46.5K | 0.03% | 134 |
|
2024
Q1 | $148K | Sell |
254
-15
| -6% | -$8.72K | 0.05% | 127 |
|
2023
Q4 | $143K | Buy |
269
+151
| +128% | +$80.2K | 0.06% | 79 |
|
2023
Q3 | $59.7K | Buy |
118
+29
| +33% | +$14.7K | 0.03% | 132 |
|
2023
Q2 | $46.4K | Sell |
89
-273
| -75% | -$142K | 0.02% | 143 |
|
2023
Q1 | $209K | Sell |
362
-47
| -11% | -$27.1K | 0.12% | 66 |
|
2022
Q4 | $225K | Sell |
409
-15
| -4% | -$8.26K | 0.15% | 69 |
|
2022
Q3 | $215K | Sell |
424
-975
| -70% | -$494K | 0.15% | 72 |
|
2022
Q2 | $763K | Buy |
1,399
+22
| +2% | +$12K | 0.48% | 69 |
|
2022
Q1 | $813K | Buy |
+1,377
| New | +$813K | 0.46% | 64 |
|
2021
Q2 | $692K | Sell |
1,372
-267
| -16% | -$135K | 0.43% | 63 |
|
2021
Q1 | $748K | Buy |
1,639
+533
| +48% | +$243K | 0.56% | 60 |
|
2020
Q4 | $515K | Buy |
+1,106
| New | +$515K | 0.43% | 67 |
|